R & D
ORIGINAL RESEARCH AND PARTNERSHIPS ARE FUNDAMENTAL GROWTH DRIVERS
Our product pipeline comprises drugs and drug candidates in various development phases in order to ensure a balanced use of resources and a continuous flow of new products for market introduction.
Drugs are sourced either internally through original research activities or externally through partnerships with other pharmaceutical companies.
Recordati is committed to the research and development of treatments for rare diseases and of new specialties within the area of urology.